[FNNews] C&R Research expands globally through CRO business
Growth Research assessed that C&R Research has the potential to expand its global influence through its Clinical Research Organization (CRO) business.
The CRO business involves conducting research and development activities on behalf of pharmaceutical companies during the development process of new and improved drugs. The global CRO market is projected to grow at an average annual rate of 10.5% until 2027.
The increasing trend of domestic clients conducting clinical trials overseas is also considered a favorable environment for C&R Research.
Please check out further details by following the link below.
